Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Q2 2025 Earnings Call Transcript August 5, 2025
Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.25, expectations were $0.18.
Operator: Good morning, and welcome to the Amneal Pharmaceuticals Second Quarter 2025 Earnings Call. I will now turn the call over to Amneal’s Head of Investor Relations, Tony DiMeo.
Anthony DiMeo: Good morning, and thank you for joining Amneal Pharmaceuticals Second Quarter 2025 Earnings Call....
